Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; penciclovir]

Antimicrobial Agents and Chemotherapy

Volumn 33, Issue 10, 1989, Pages 1765-1773

  Hodge, R A V ^a   Sutton, D ^a   Boyd, M R ^a   Harnden, M R ^a   Jarvest, R L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 DEOXYPENCICLOVIR; 6 DEOXYPENCICLOVIR DIPROPIONATE; ACICLOVIR; DESCICLOVIR; FAMCICLOVIR; FAMCICLOVIR DIPROPIONATE; PENCICLOVIR; PENCICLOVIR DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; BIOAVAILABILITY; BLOOD LEVEL; DRUG ABSORPTION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

EID: 0024416237     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.33.10.1765     Document Type: Article

References (0)